Gabelli Funds’s Epizyme, Inc EPZM Stock Holding History

Gabelli Funds’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-852,105	Closed	-$1.25M	–	1443
2022 Q2	$1.25M	Buy	+852,105	New	+$626K	0.01%	788

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Gabelli Funds's EPZM Position: Q3 2022 in Review

Gabelli Funds sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 852,105 shares — an estimated $1.25M sold.

Gabelli Funds first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $1.25M in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Gabelli Funds reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Gabelli Funds sold 852,105 Epizyme, Inc shares in Q3 2022, an estimated $1.25M.
Gabelli Funds first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Gabelli Funds's Epizyme, Inc position peaked at $1.25M in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Gabelli Funds's 13F filing for Q3 2022, filed 10 Nov 2022.